En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy
- PMID: 24289918
- PMCID: PMC3943670
- DOI: 10.1016/j.ophtha.2013.10.014
En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy
Abstract
Objective: To characterize en face features of the retinal pigment epithelium (RPE) and choroid in eyes with chronic central serous chorioretinopathy (CSCR) using a high-speed, enhanced-depth swept-source optical coherence tomography (SS-OCT) prototype.
Design: Consecutive patients with chronic CSCR were prospectively examined with SS-OCT.
Participants: Fifteen eyes of 13 patients.
Methods: Three-dimensional 6×6 mm macular cube raster scans were obtained with SS-OCT operating at 1050 nm wavelength and 100000 A-lines/sec with 6 μm axial resolution. Segmentation of the RPE generated a reference surface; en face SS-OCT images of the RPE and choroid were extracted at varying depths every 3.5 μm (1 pixel). Abnormal features were characterized by systematic analysis of multimodal fundus imaging, including color photographs, fundus autofluorescence, fluorescein angiography, and indocyanine-green angiography (ICGA).
Main outcome measures: En face SS-OCT morphology of the RPE and individual choroidal layers.
Results: En face SS-OCT imaging at the RPE level revealed absence of signal corresponding to RPE detachment or RPE loss in 15 of 15 (100%) eyes. En face SS-OCT imaging at the choriocapillaris level showed focally enlarged vessels in 8 of 15 eyes (53%). At the level of Sattler's layer, en face SS-OCT documented focal choroidal dilation in 8 of 15 eyes (53%) and diffuse choroidal dilation in 7 of 15 eyes (47%). At the level of Haller's layer, these same features were observed in 3 of 15 eyes (20%) and 12 of 15 eyes (80%), respectively. In all affected eyes, these choroidal vascular abnormalities were seen just below areas of RPE abnormalities. In 2 eyes with secondary choroidal neovascularization (CNV), distinct en face SS-OCT features corresponded to the neovascular lesions.
Conclusions: High-speed, enhanced-depth SS-OCT at 1050 nm wavelength enables the visualization of pathologic features of the RPE and choroid in eyes with chronic CSCR not usually appreciated with standard spectral domain (SD) OCT. En face SS-OCT imaging seems to be a useful tool in the identification of CNV without the use of angiography. This in vivo documentation of the RPE and choroidal vasculature at variable depths may help elucidate the pathophysiology of disease and can contribute to the diagnosis and management of chronic CSCR.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Figures




Similar articles
-
En face choroidal vascular feature imaging in acute and chronic central serous chorioretinopathy using swept source optical coherence tomography.Br J Ophthalmol. 2017 May;101(5):580-586. doi: 10.1136/bjophthalmol-2016-308428. Epub 2016 Aug 2. Br J Ophthalmol. 2017. PMID: 27485721
-
En face swept-source optical coherence tomography in neovascular age-related macular degeneration.Br J Ophthalmol. 2015 Sep;99(9):1260-7. doi: 10.1136/bjophthalmol-2014-306422. Epub 2015 Feb 26. Br J Ophthalmol. 2015. PMID: 25722493
-
Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.Am J Ophthalmol. 2015 Sep;160(3):581-587.e1. doi: 10.1016/j.ajo.2015.06.016. Epub 2015 Jun 29. Am J Ophthalmol. 2015. PMID: 26133250
-
[Pathophysiology of macular diseases--morphology and function].Nippon Ganka Gakkai Zasshi. 2011 Mar;115(3):238-74; discussion 275. Nippon Ganka Gakkai Zasshi. 2011. PMID: 21476310 Review. Japanese.
-
FOCAL CHOROIDAL EXCAVATION AND ITS ASSOCIATION WITH PACHYCHOROID SPECTRUM DISORDERS: A Review of the Literature and Multimodal Imaging Findings.Retina. 2017 Feb;37(2):199-221. doi: 10.1097/IAE.0000000000001345. Retina. 2017. PMID: 27749784 Review.
Cited by
-
Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography.Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT341-7. doi: 10.1167/iovs.15-18715. Invest Ophthalmol Vis Sci. 2016. PMID: 27409491 Free PMC article.
-
Choroidal biomarkers.Indian J Ophthalmol. 2018 Dec;66(12):1716-1726. doi: 10.4103/ijo.IJO_893_18. Indian J Ophthalmol. 2018. PMID: 30451172 Free PMC article. Review.
-
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.BMC Ophthalmol. 2014 Nov 25;14:145. doi: 10.1186/1471-2415-14-145. BMC Ophthalmol. 2014. PMID: 25421855 Free PMC article.
-
Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy.J Ophthalmol. 2015;2015:134783. doi: 10.1155/2015/134783. Epub 2015 Nov 8. J Ophthalmol. 2015. PMID: 26634150 Free PMC article.
-
Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration.Int J Retina Vitreous. 2022 Oct 23;8(1):78. doi: 10.1186/s40942-022-00429-6. Int J Retina Vitreous. 2022. PMID: 36274175 Free PMC article.
References
-
- Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol. 1967;63(suppl):1–139. - PubMed
-
- Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554–72. - PubMed
-
- Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger adults. Ophthalmology. 1996;103:2070–9. - PubMed
-
- Kitzmann AS, Pulido JS, Diehl NN, et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008;115:169–73. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R44-EY022864-01/EY/NEI NIH HHS/United States
- R01 CA075289/CA/NCI NIH HHS/United States
- R01 NS057476/NS/NINDS NIH HHS/United States
- R01-EY013178-12/EY/NEI NIH HHS/United States
- R01-EY018184-05/EY/NEI NIH HHS/United States
- R01 EY018184/EY/NEI NIH HHS/United States
- R01-CA075289-16/CA/NCI NIH HHS/United States
- R01 EY011289/EY/NEI NIH HHS/United States
- R44 EY022864/EY/NEI NIH HHS/United States
- R01-NS057476-05/NS/NINDS NIH HHS/United States
- R44EY022864-01/EY/NEI NIH HHS/United States
- R01 EY013178/EY/NEI NIH HHS/United States
- R01-EY011289-27/EY/NEI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials